BRAF and melanoma: In that same study, the knockdown of SOD2 expression in resistant melanoma cells inhibited proliferation, while the administration of the exogenous antioxidant, N-acetyl cysteine, re-sensitized resistant cells to BRAF-inhibitor treatment.